These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2897208)

  • 1. Platelet vinculin: a substrate of activated factor XIII.
    Asijee GM; Muszbek L; Kappelmayer J; Polgár J; Horváth A; Sturk A
    Biochim Biophys Acta; 1988 Jun; 954(3):303-8. PubMed ID: 2897208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation.
    Serrano K; Devine DV
    Thromb Haemost; 2002 Aug; 88(2):315-20. PubMed ID: 12195706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinculin is a permanent component of the membrane skeleton and is incorporated into the (re)organising cytoskeleton upon platelet activation.
    Asijee GM; Sturk A; Bruin T; Wilkinson JM; Ten Cate JW
    Eur J Biochem; 1990 Apr; 189(1):131-6. PubMed ID: 2110061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L; Adány R; Mikkola H
    Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of vinculin to the platelet cytoskeleton during thrombin-induced aggregation.
    Asyee GM; Sturk A; Muszbek L
    Exp Cell Res; 1987 Feb; 168(2):358-64. PubMed ID: 3100318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
    Jeleńska MM; Fesüs L; Kopeć M
    Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of thrombospondin as a substrate for factor XIII transglutaminase.
    Lynch GW; Slayter HS; Miller BE; McDonagh J
    J Biol Chem; 1987 Feb; 262(4):1772-8. PubMed ID: 2879842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of plasma factor XIII to thrombin-receptor activated human platelets.
    Nagy B; Simon Z; Bagoly Z; Muszbek L; Kappelmayer J
    Thromb Haemost; 2009 Jul; 102(1):83-9. PubMed ID: 19572072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).
    Mouapi KN; Wagner LJ; Stephens CA; Hindi MM; Wilkey DW; Merchant ML; Maurer MC
    Thromb Haemost; 2019 Jul; 119(7):1048-1057. PubMed ID: 31055797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin.
    Achyuthan KE; Rowland TC; Birckbichler PJ; Lee KN; Bishop PD; Achyuthan AM
    Mol Cell Biochem; 1996 Sep; 162(1):43-9. PubMed ID: 8905624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrates of Factor XIII-A: roles in thrombosis and wound healing.
    Richardson VR; Cordell P; Standeven KF; Carter AM
    Clin Sci (Lond); 2013 Feb; 124(3):123-37. PubMed ID: 23075332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
    Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
    Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of factor XIII activity in plasma.
    Katona É; Pénzes K; Molnár É; Muszbek L
    Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin.
    Wang DL; Annamalai AE; Ghosh S; Gewirtz AM; Colman RW
    Thromb Res; 1990 Jan; 57(1):39-57. PubMed ID: 2300924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet factor XIII is activated by calpain.
    Ando Y; Imamura S; Yamagata Y; Kitahara A; Saji H; Murachi T; Kannagi R
    Biochem Biophys Res Commun; 1987 Apr; 144(1):484-90. PubMed ID: 2883970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin is a substrate for blood coagulation factor XIIIa.
    Bale MD; Mosher DF
    Biochemistry; 1986 Sep; 25(19):5667-73. PubMed ID: 2877688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.